Zai Lab (ZLAB) Income towards Parent Company (2018 - 2026)

Zai Lab (ZLAB) posted Income towards Parent Company of -$51.0 million for Q1 2026, down 1.2% sequentially from -$50.4 million in Q4 2025, and down 5.32% YoY from -$53.9 million in Q1 2025.

Zai Lab (ZLAB) Income towards Parent Company (2018 - 2026) Analysis & Trends

Zai Lab has reported Income towards Parent Company for 9 years, with the latest figure at -$51.0 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 5.32% year-over-year to -$51.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$178.1 million (up 29.34% YoY) and the FY2025 annual result came in at -$175.5 million, up 31.73% from the prior year.
  • Income towards Parent Company retreated to -$51.0 million in Q1 2026 per ZLAB's latest filing, from -$50.4 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$36.0 million in Q3 2025 and troughed at -$161.2 million in Q3 2022.
  • A 5-year average of -$74.2 million and a median of -$61.8 million in 2022 frame the typical range for Income towards Parent Company.
  • The widest YoY moves for Income towards Parent Company: up 70.77% in 2022, down 67.78% in 2022.
  • Over 5 years, Income towards Parent Company stood at -$61.8 million in 2022, then plunged by 54.49% to -$95.4 million in 2023, then increased by 14.4% to -$81.7 million in 2024, then surged by 38.29% to -$50.4 million in 2025, then declined by 1.2% to -$51.0 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$51.0 million, -$50.4 million, and -$36.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.83 Mn
Mar 31, 2026 -51.02 Mn
Dec 31, 2025 -50.41 Mn
Sep 30, 2025 -35.96 Mn
Jun 30, 2025 -40.73 Mn
Mar 31, 2025 -48.44 Mn
Dec 31, 2024 -81.68 Mn
Sep 30, 2024 -41.67 Mn
Jun 30, 2024 -80.28 Mn
Mar 31, 2024 -53.47 Mn
Dec 31, 2023 -95.43 Mn
Sep 30, 2023 -69.15 Mn
Jun 30, 2023 -120.90 Mn
Mar 31, 2023 -49.14 Mn
Dec 31, 2022 -61.77 Mn
Sep 30, 2022 -161.19 Mn
Jun 30, 2022 -137.93 Mn
Mar 31, 2022 -82.17 Mn
Dec 31, 2021 -211.32 Mn
Sep 30, 2021 -96.07 Mn